In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 14-426V 

Filed: February 12, 2016 

Not for Publication 

************************************* 

CHUN-XIANG MAO, * 

* 

Petitioner, * 

 * 

 v. * 

 * 

SECRETARY OF HEALTH * 

AND HUMAN SERVICES, * 

 * 

 Respondent. * 

* 

************************************* 

Alfonso L. Melendez, El Paso, TX, for petitioner. 

Amy P. Kokot, Washington, DC, for respondent. 

MILLMAN, Special Master

DECISION AWARDING DAMAGES1

On February 12, 2016, the parties filed the attached stipulation in which they agreed to 

settle this case and described the settlement terms. Petitioner alleges that he suffered from 

meningoencephalitis that was caused by his receipt of the influenza, hepatitis B, human 

papillomavirus, meningococcal, measles-mumps-rubella, tetanus-diphtheria-acellular pertussis, 

and varicella vaccines on or about June 14, 2011. He further alleges that he experienced the 

residual effects of this injury for more than six months. Respondent denies that the influenza, 

hepatitis B, human papillomavirus, meningococcal, measles-mumps-rubella, tetanus-diphtheriaacellular pertussis, or varicella vaccines caused petitioner to suffer meningoencephalitis or any 

other injury or his current condition and that he experienced the residual effects of this injury for 

1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this 

case, the special master intends to post this unpublished decision on the United States Court of Federal 

Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 

2899, 2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be 

made available to the public unless they contain trade secrets or commercial or financial information that 

is privileged and confidential, or medical or similar information whose disclosure would constitute a 

clearly unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify 

and move to delete such information prior to the document’s disclosure. If the special master, upon 

review, agrees that the identified material fits within the banned categories listed above, the special 

master shall delete such material from public access.

Damages decision based on stipulation; 

influenza vaccine; hepatitis B vaccine; 

human papillomavirus vaccine; 

meningococcal vaccine; measles-mumpsrubella vaccine; tetanus-diphtheria-acellular 

pertussis vaccine; varicella vaccine; 

meningoencephalitis

 
more than six months. Nonetheless, the parties agreed to resolve this matter informally.

 The undersigned finds the terms of the stipulation to be reasonable. The court hereby 

adopts the parties’ said stipulation, attached hereto, and awards compensation in the amount and 

on the terms set forth therein. Pursuant to the stipulation, the court awards a lump sum of 

$192,500.00, representing compensation for all damages that would be available under 42 U.S.C. 

§ 300aa-15(a) (2012). The award shall be in the form of a check for $192,500.00 made payable 

to petitioner.

 In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of 

the court is directed to enter judgment herewith.2

IT IS SO ORDERED.

Dated: February 12, 2016 s/ Laura D. Millman

 Laura D. Millman

 Special Master

2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or 

jointly, filing a notice renouncing the right to seek review.

2